Armata Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +25.5% | -61.0% | +65.3% | -15.4% | +542.1% | -19.3% | -25.8% | +9.4% | +21.3% | -30.3% | -64.2% | +63.0% | -74.9% | -23.8% | +110.6% | +92.3% | +71.9% | -24.6% | +10.0% | -42.2% | -38.8% | +6.7% | +114.1% | +55.3% | +76.6% | +54.6% | -8.8% | -12.1% | -11.1% | |
| – | +33.6% | -72.8% | +134.0% | -25.0% | +353.6% | -30.1% | -51.8% | +52.0% | +62.5% | -56.8% | -45.8% | +134.3% | -70.6% | -6.3% | -69.5% | +1.9% | +1,143.7% | -65.8% | +42.7% | -36.6% | -15.3% | +56.1% | -20.8% | +63.0% | +38.3% | +80.4% | -29.2% | -41.0% | -5.7% | |
| – | +59.1% | -71.4% | +90.0% | +115.8% | +842.2% | -34.8% | -49.9% | +67.0% | +61.9% | -58.6% | -56.1% | +164.9% | -68.3% | -2.8% | -78.3% | -21.6% | +2,261.4% | -67.7% | +42.4% | -39.1% | -10.1% | +58.9% | -26.0% | +59.9% | +6.6% | +44.4% | -8.9% | -31.3% | -6.5% | |
| – | +59.1% | -71.4% | +90.0% | +278.9% | +436.5% | -34.8% | -49.9% | +67.0% | +61.9% | -58.6% | -56.1% | +164.9% | -68.3% | -2.8% | -78.3% | -21.6% | +2,261.4% | -67.7% | +42.4% | -39.1% | -10.1% | +58.9% | -26.0% | +59.9% | +6.6% | +44.4% | -8.9% | -31.3% | -6.5% | |
| – | – | – | – | – | +81.3% | +3.2% | -65.3% | -85.8% | +143.4% | -5.9% | +294.2% | +74.3% | -87.9% | – | – | +434.2% | -98.8% | +1,150.0% | +25.0% | -80.0% | – | – | – | – | +432.8% | +185.4% | -60.6% | -77.9% | -36.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5.2% | +256.5% | -15.0% | +29.7% | +204.6% | -82.7% | +62.9% | – | – | – | |
| – | – | – | – | – | – | – | – | -100.0% | +0.0% | +0.0% | -75.0% | +0.0% | – | – | – | -23.9% | -41.6% | +74.7% | +0.0% | -100.0% | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | -16.0% | -0.3% | +0.0% | +0.0% | +0.0% | – | – | – | – | – | – | +0.5% | -1.0% | -0.2% | -15.8% | -54.2% | -39.7% | +244.6% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +33.3% | -25.0% | +0.0% | +59.5% | +266.3% | +37.1% | +37.0% | -49.1% | -13.8% | -9.8% | -33.6% | +1.1% | -10.7% | -91.6% | +370.7% | +110.8% | +471.5% | -51.7% | -25.4% | -54.9% | -59.8% | +0.2% | +218.1% | +90.3% | +114.8% | +61.8% | +81.7% | +3.1% | +119.8% | |
| – | +94.4% | -22.9% | +22.2% | +39.4% | +175.8% | -8.3% | -3.0% | -40.5% | -40.5% | +15.8% | +12.1% | -10.2% | -14.4% | -76.9% | +64.1% | +300.7% | -64.5% | -13.0% | +27.7% | +50.1% | -45.0% | +30.7% | +89.7% | +37.4% | -28.2% | +416.7% | -33.8% | +193.1% | -81.5% | |
| – | +44.4% | -23.1% | +20.0% | +0.0% | -30.2% | +56.1% | -0.8% | -0.6% | -1.6% | -87.8% | +628.4% | -70.2% | – | – | – | – | – | – | – | – | -100.0% | – | – | +73.8% | -33.6% | +1,027.3% | -44.3% | +357.6% | -89.5% | |
| – | +216.7% | -26.3% | +21.4% | +35.3% | +73.9% | -13.7% | -41.7% | -36.8% | +1.4% | +37.3% | +7.4% | +13.7% | – | – | – | – | +10.8% | -45.6% | -10.5% | +1.1% | -45.3% | +26.1% | -25.0% | +74.8% | +19.0% | +47.5% | -5.5% | -51.7% | +20.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -32.6% | +363.5% | |
| – | +23.4% | -71.3% | +114.3% | -41.7% | +806.2% | -41.0% | -84.2% | +467.8% | +48.6% | -38.6% | -82.4% | +202.6% | -123.2% | – | +57.8% | +81.0% | -209.9% | – | +269.9% | -23.5% | -20.5% | +9.6% | +72.2% | +29.2% | +34.7% | +42.1% | -188.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +55.8% | +23.1% | +31.9% | +20.8% | +17.3% | -91.7% | +4.2% | +25.6% | +38.2% | +7.8% | +14.3% | +68.6% | +20.9% | +3.1% | +240.5% | -31.4% | +110.7% | +219.8% | -16.4% | -81.8% | +6,392.7% | -27.2% | +2,255.2% | +109.7% | +46.8% | +42.3% | +5.2% | +0.2% | +0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.